To include your compound in the COVID-19 Resource Center, submit it here.
Pharmasset expanded the U.S. Phase IIb ELECTRON trial evaluating 400 mg PSI-7977 daily to include 3 cohorts and an additional 30
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury